BMS 1612 (Baraclude 1 mg)
Generic Name: entecavir
Pill imprint BMS 1612 has been identified as Baraclude 1 mg.
Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 1 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BMS 1612 (Baraclude 1 mg)
- Generic Name:
- entecavir
- Imprint:
-
BMS
1612 - Strength:
- 1 mg
- Color:
- Pink
- Shape:
- Three-sided
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Bristol-Myers Squibb
- National Drug Code (NDC):
- 00003-1612
- Inactive Ingredients:
- lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
ferric oxide red
More resources
Baraclude is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

